Department of Chemical Engineering, University of Illinois at Chicago, Chicago, IL 60607, USA.
Biomater Sci. 2021 Feb 23;9(4):1381-1396. doi: 10.1039/d0bm01967d.
Bioresorbable polymers, including polyesters and polypeptides, are being widely used in the medical field. However, these materials still suffer from some long-standing challenges, such as material-induced blood coagulation, foreign body response, non-adjustable degradation rate, and absence of elastic properties. In this work, we explored a new approach to address these challenges by incorporating critical anti-fouling, improved mechanical and controllable degradation properties into the existing bioresorbable polymers. We synthesized a set of zwitterionic thermoplastic polyurethanes, which consist of degradable polycaprolactone diols as soft segments and faster hydrolyzable carboxybetaine (CB) diols as chain extenders. Differential scanning calorimetry and temperature sweep rheology revealed thermal transition performance and thermoplastic behavior of the polymers. The calorimetric study observed that CB-based chain extender played a critical role in the crystallization process by affecting the structure and crystallization temperature. Cell attachment study demonstrated that the degradable zwitterionic polyurethane surfaces highly resist cell attachment even after being submerged in 100% fetal bovine serum for two weeks. The gold standard PEG-based degradable polyurethane showed the initial resistance to the cell attachment for one day and then failed after three days. This work clearly shows that the adaption of existing materials with slightly better anti-fouling properties is unlikely to solve these long-lasting challenges. Our design approach and the material platform with critical anti-fouling properties and other desired tunable properties show the potential to address these complications associated with existing bioresorbable polymers. This method can be adapted to design customized bioresorbable polymers for a wide range of applications, including implantable biomedical devices and drug delivery.
生物可吸收聚合物,包括聚酯和多肽,在医学领域得到了广泛应用。然而,这些材料仍然存在一些长期存在的挑战,如材料诱导的血液凝固、异物反应、不可调节的降解率和缺乏弹性性能。在这项工作中,我们探索了一种新的方法,通过将关键的抗污、改进的机械性能和可控的降解性能纳入现有的生物可吸收聚合物来解决这些挑战。我们合成了一系列两性离子热塑性聚氨酯,它由可降解的聚己内酯二醇作为软段和更快水解的羧基甜菜碱(CB)二醇作为扩链剂组成。差示扫描量热法和温度扫描流变学揭示了聚合物的热转变性能和热塑性行为。量热研究观察到,CB 基扩链剂通过影响结构和结晶温度,在结晶过程中起着关键作用。细胞附着研究表明,即使在 100%胎牛血清中浸泡两周后,可降解两性离子聚氨酯表面仍高度抵抗细胞附着。基于 PEG 的可降解聚氨酯的金标准显示出对细胞附着的最初抵抗性,持续一天,然后在三天后失效。这项工作清楚地表明,适应现有材料并略微提高抗污性能不太可能解决这些长期存在的挑战。我们的设计方法和具有关键抗污性能和其他所需可调性能的材料平台显示出解决与现有生物可吸收聚合物相关的这些并发症的潜力。这种方法可以适用于设计各种应用的定制生物可吸收聚合物,包括可植入的生物医学设备和药物输送。